WHITEHAWK THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $28.00K, a 16.67% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $24.00K, a 74.47% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $66.00K.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $94.00K, a 68.03% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $49.00K, a 66.44% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $146.00K, a 64.22% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $408.00K, a 26.32% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $323.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $28.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $49.00K 10-K · filed 2026-03-12 | |
| 2025-06-30 | $24.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $146.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $66.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $94.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $408.00K 10-K · filed 2025-03-28 | |
| 2023-06-30 | $294.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $323.00K 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |